MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 187 filers reported holding MEDICINES CO in Q1 2015. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,994,000 | +81.4% | 58,798 | +6.8% | 0.04% | +72.7% |
| Q3 2019 | $2,753,000 | -7.5% | 55,052 | -32.6% | 0.02% | -8.3% |
| Q2 2019 | $2,977,000 | +28.5% | 81,640 | -1.5% | 0.02% | +26.3% |
| Q1 2019 | $2,316,000 | +36.9% | 82,874 | -6.3% | 0.02% | +35.7% |
| Q4 2018 | $1,692,000 | -37.1% | 88,407 | -1.7% | 0.01% | -22.2% |
| Q3 2018 | $2,690,000 | -14.3% | 89,929 | +5.2% | 0.02% | -14.3% |
| Q2 2018 | $3,138,000 | +6.5% | 85,502 | -4.4% | 0.02% | +200.0% |
| Q1 2018 | $2,946,000 | +7.4% | 89,463 | -10.9% | 0.01% | +16.7% |
| Q4 2017 | $2,743,000 | -40.2% | 100,424 | -18.8% | 0.01% | -45.5% |
| Q3 2017 | $4,584,000 | +25.1% | 123,742 | +28.4% | 0.01% | +10.0% |
| Q2 2017 | $3,664,000 | -3.0% | 96,363 | +24.8% | 0.01% | 0.0% |
| Q1 2017 | $3,776,000 | +35.4% | 77,192 | -6.0% | 0.01% | +25.0% |
| Q4 2016 | $2,788,000 | -25.8% | 82,134 | -17.5% | 0.01% | -33.3% |
| Q3 2016 | $3,756,000 | +7.0% | 99,514 | -4.7% | 0.01% | +9.1% |
| Q2 2016 | $3,511,000 | -1.0% | 104,394 | -6.5% | 0.01% | 0.0% |
| Q1 2016 | $3,547,000 | -39.9% | 111,655 | -29.4% | 0.01% | -35.3% |
| Q4 2015 | $5,906,000 | -20.7% | 158,185 | -19.4% | 0.02% | -26.1% |
| Q3 2015 | $7,451,000 | -3.6% | 196,303 | -27.4% | 0.02% | +21.1% |
| Q2 2015 | $7,731,000 | +19.2% | 270,228 | +16.8% | 0.02% | +26.7% |
| Q1 2015 | $6,484,000 | +49.4% | 231,417 | +47.5% | 0.02% | +36.4% |
| Q4 2014 | $4,341,000 | +7.1% | 156,892 | -13.6% | 0.01% | +10.0% |
| Q3 2014 | $4,054,000 | -18.2% | 181,649 | +6.6% | 0.01% | -23.1% |
| Q2 2014 | $4,953,000 | -15.6% | 170,446 | -17.4% | 0.01% | -23.5% |
| Q1 2014 | $5,866,000 | -12.7% | 206,405 | +18.6% | 0.02% | -15.0% |
| Q4 2013 | $6,723,000 | +9.8% | 174,084 | -4.7% | 0.02% | -9.1% |
| Q3 2013 | $6,122,000 | +47.0% | 182,652 | +34.9% | 0.02% | +22.2% |
| Q2 2013 | $4,166,000 | – | 135,423 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |